{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Daily Compounding Effect",
        "Short Exposure",
        "High Risk Rating"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) designed to provide -3x the daily return of the iShares MSCI Japan ETF, indicating triple leverage and inverse exposure. The replication method is physical, holding underlying assets directly (short positions in the iShares MSCI Japan ETF stock and cash balances), with no indication of synthetic replication or swap usage. The product explicitly states the use of leverage (-3x) and inverse exposure, with a recommended holding period of only 1 day due to the compounding effect, which can cause returns over longer periods to deviate significantly from the expected multiple of the underlying. The risk indicator is high (6 out of 7), reflecting the amplified risk from leverage and inverse exposure. There is no capital protection, and investors can lose the entire investment. The product is not UCITS compliant. The complexity arises primarily from the leverage and inverse nature of the product, the daily rebalancing and compounding effects, and the high risk profile, which make it difficult for retail investors to understand and manage. No swaps or derivative instruments are used as part of the replication strategy, and derivatives are only used indirectly through the short positions in the underlying ETF stock. The PRIIPs KID and factsheet confirm the physical replication and absence of swap agreements. The product is classified as complex under MiFID II due to leverage, inverse exposure, and the associated risks and complexity of the investment strategy."
}